F/m Emerald Life Sciences Innovation ETF Rating $23.55 +0.37 (+1.60%) Closing price 03:59 PM EasternExtended Trading$23.45 -0.10 (-0.42%) As of 04:05 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartHoldingsOwnershipRatingsTrendsBuy This Stock F/m Emerald Life Sciences Innovation ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.LFSC Aggregate RatingModerate Buy 2.94Holdings in LFSC have an aggregate rating of Moderate Buy based on 331 analyst ratings issued in the past year covering 29 companies (99.1% of the portfolio).LFSC Aggregate Price Target$23.55High Prediction$23.55Average Prediction$23.55Low Prediction$23.55Holdings in LFSC have an aggregate price target of $23.55 and a range of $23.55 to $23.55 covering 29 companies (99.1% of the portfolio).LFSC Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy12 Buy rating(s)Moderate Buy17 Moderate Buy rating(s)Hold0 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by F/m Emerald Life Sciences Innovation ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 29 LFSC Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings7.62%BBIOBridgeBio Pharma$38.57+0.4%4.5814 of 5 stars2.92$57.09 48.0%12Earnings ReportAnalyst ForecastAnalyst RevisionNews Coverage7.27%SLNOSoleno Therapeutics$75.23+0.3%4.6605 of 5 stars3.20$104.67 39.1%10Upcoming EarningsNews CoveragePositive News6.99%RDNTRadNet$53.38+2.2%4.0641 of 5 stars3.40$69.75 30.7%5Positive News6.10%BPMCBlueprint Medicines$104.64+5.4%1.7426 of 5 stars2.68$124.53 19.0%22Earnings ReportAnalyst ForecastNews CoveragePositive News5.78%MMSIMerit Medical Systems$95.66+2.6%3.9899 of 5 stars3.00$107.78 12.7%10Short Interest ↑4.80%LIVNLivaNova$36.780.0%3.8205 of 5 stars2.88$61.17 66.3%8Upcoming EarningsNews CoveragePositive News4.65%TMDXTransMedics Group$89.98-0.5%3.2327 of 5 stars2.82$124.20 38.0%11Upcoming EarningsAnalyst ForecastPositive News4.54%TVTXTravere Therapeutics$21.15+1.9%2.9046 of 5 stars2.87$31.79 50.3%15Earnings ReportAnalyst ForecastNews CoveragePositive News4.41%RAREUltragenyx Pharmaceutical$39.30+0.8%4.3822 of 5 stars2.93$92.79 136.1%14Upcoming EarningsShort Interest ↑Positive News4.37%COLLCollegium Pharmaceutical$27.65+2.2%4.0558 of 5 stars2.80$43.60 57.7%5Upcoming EarningsPositive News4.19%MDGLMadrigal Pharmaceuticals$315.48-3.7%4.6199 of 5 stars2.90$416.33 32.0%10Earnings ReportAnalyst ForecastNews CoveragePositive News3.87%INSMInsmed$72.30-0.5%4.3943 of 5 stars3.00$94.00 30.0%16Upcoming EarningsNews CoveragePositive News3.73%ATECAlphatec$12.00+8.5%4.0569 of 5 stars2.89$17.89 49.1%9Earnings ReportAnalyst ForecastShort Interest ↑News CoveragePositive NewsHigh Trading Volume3.62%GHGuardant Health$46.85-4.1%4.5367 of 5 stars3.05$51.64 10.2%22Earnings ReportAnalyst ForecastNews CoveragePositive NewsGap UpHigh Trading Volume3.01%WVEWave Life Sciences$8.10+2.0%4.2426 of 5 stars3.00$21.17 161.3%12Upcoming EarningsAnalyst ForecastAnalyst RevisionNews CoverageHigh Trading Volume2.45%ETNB89bio$8.73+7.4%3.0004 of 5 stars3.00$27.25 212.1%9Earnings ReportUpcoming EarningsAnalyst UpgradeAnalyst RevisionNews CoveragePositive NewsGap Up2.27%AKROAkero Therapeutics$44.87-1.0%3.7972 of 5 stars3.00$76.29 70.0%9Upcoming EarningsNews CoveragePositive News2.21%ACADACADIA Pharmaceuticals$14.91+2.3%4.2732 of 5 stars2.50$23.87 60.1%16Upcoming Earnings2.21%NEONeoGenomics$7.70+6.1%3.2441 of 5 stars2.50$14.50 88.3%10Earnings ReportAnalyst ForecastNews CoverageHigh Trading Volume2.18%GMEDGlobus Medical$71.90+1.1%4.8562 of 5 stars2.75$96.91 34.8%12Upcoming EarningsShort Interest ↑Positive News2.06%SRPTSarepta Therapeutics$63.51+1.2%4.7694 of 5 stars2.83$158.70 149.9%241.65%BHVNBiohaven$22.76+1.4%3.6577 of 5 stars3.07$62.54 174.8%15Upcoming EarningsGap Up1.62%UTHRUnited Therapeutics$294.60+0.3%4.9886 of 5 stars2.67$392.00 33.1%12Earnings ReportAnalyst ForecastInsider TradePositive News1.41%SYRESpyre Therapeutics$15.11+3.1%1.9423 of 5 stars3.20$49.57 228.1%10Upcoming EarningsNews CoveragePositive News1.34%SVRASavara$3.40+4.3%1.7274 of 5 stars2.83$8.83 159.8%6Upcoming EarningsNews Coverage1.25%NVCRNovoCure$18.15+1.1%3.8931 of 5 stars2.67$32.83 80.9%61.20%KALVKalVista Pharmaceuticals$13.55-0.4%3.9244 of 5 stars3.13$24.83 83.3%8News CoveragePositive News1.18%OFIXOrthofix Medical$13.79+1.8%3.1961 of 5 stars3.00$23.33 69.2%4Upcoming Earnings1.11%ITGRInteger$125.64+0.0%2.1203 of 5 stars2.78$145.56 15.9%9 This page (NASDAQ:LFSC) was last updated on 5/2/2025 by MarketBeat.com Staff From Our PartnersThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | SponsoredTrump Orders 'National Digital Asset Stockpile'Billionaires Rush Into Digital Banking Token Three massive forces are converging right now, creating what c...Crypto 101 Media | SponsoredElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding F/m Emerald Life Sciences Innovation ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share F/m Emerald Life Sciences Innovation ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy LFSC Stock Free LFSC Stock Alerts